TITLE

Zebra Lines of Pamidronate Therapy in Children

AUTHOR(S)
Muderis, M. Al; Azzopardi, T.; Cundy, P.
PUB. DATE
July 2007
SOURCE
Journal of Bone & Joint Surgery, American Volume;Jul2007, Vol. 89-A Issue 7, p1511
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Pamidronate therapy is increasingly used in children for the treatment of low bone mineral density and increased bone fragility resulting from a spectrum of conditions. The aim of the present study was to determine and describe the radiographic features associated with cyclical bisphosphonate therapy in the growing skeleton. Methods: A retrospective review of the radiographs of thirty-five children who had been managed with cyclical pamidronate was carried out. The physeal growth rates were estimated by measuring the band intervals on radiographs and the corresponding time intervals between the administered doses of pamidronate. Results: Metaphyseal bands, which we call zebra lines, were observed with band intervals that were dependent on the age of the patient, the rate of growth, and the dosing regimen. Epiphyseal and apophyseal bands were also observed in some patients. A distinction was made between Harris growth arrest lines and zebra lines. There was no evidence to suggest a deceleration in bone growth in children managed with pamidronate. Conclusions: The term zebra lines is proposed as a descriptive term for the characteristic pattern of metaphyseal banding seen on the radiographs of children receiving cyclical bisphosphonate therapy.
ACCESSION #
25781162

 

Related Articles

  • Modeling the benefits of pamidronate in children with osteogenesis imperfecta. Lindsay, Robert // Journal of Clinical Investigation;11/1/2002, Vol. 110 Issue 9, p1239 

    Discusses the utility of pamidronate in children with osteogenesis imperfecta (OI). Brone growth and metabolism in OI; Effects of biphosphonates; Risks and benefits of pamidronate.

  • Pamidronate Affects the Mandibular Cortex of Children with Osteogenesis Imperfecta. Apolinário, A.C.; Figueiredo, P.T.; Guimarães, A.T.; Acevedo, A.C.; Castro, L.C.; Paula, A.P.; Paula, L.M.; Melo, N.S.; Leite, A.F. // Journal of Dental Research;2015 Supplement, Vol. 94, p95S 

    We hypothesized that mandibular cortical width (MCW) is smaller in children with osteogenesis imperfecta (OI) than in healthy children and that pamidronate can improve the cortical mandibular thickness. The aim of this study was to assess changes in the MCW on dental panoramic radiographs (DPRs)...

  • Bisphosphonate therapy for chronic recurrent multifocal osteomyelitis. Handly, Brian; Moore, Michael; Creutzberg, Gina; Groh, Brandt; Mosher, Timothy // Skeletal Radiology;Dec2013, Vol. 42 Issue 12, p1777 

    The article focuses on a case of chronic recurrent multifocal osteomyelitis treated with bisphosphonates. The patient received intravenous pamidronate for 17 months, until recrudescent disease led to a change in therapy. Information on the therapeutic effects of biphosphonates in adult patients...

  • Do Bisphosphonates Make Children's Bones Better or Brittle? Marini, Joan C. // New England Journal of Medicine;7/31/2003, Vol. 349 Issue 5, p423 

    The article examines the effect of bisphosphonates on children's bones. According to a study published within the issue, prolonged treatment with high doses of bisphosphonate pamidronate resulted in findings characteristic of osteopetrosis. It was found that bisphosphonates cause structural...

  • Bisphosphonate-Induced Osteopetrosis. Whyte, Michael P.; Wenkert, Deborah; Clements, Karen L.; McAlister, William H.; Mumm, Steven // New England Journal of Medicine;7/31/2003, Vol. 349 Issue 5, p457 

    The article discusses the case of drug-induced osteopetrosis in a male pediatric patient. It was found that osteopetrosis developed in the patient, coinciding with the administration of pamidronate. Bone densitometry revealed a supranormal whole-body value. According to the article, untoward...

  • INHIBITORY EFFECT OF BISPHOSPHONATE [PAMIDRONATE] ON ORTHODONTIC TOOTH MOVEMENT IN NEWZEALAND ALBINO RABBITS. Venkataramana, V.; Rajasigamani, K.; Madhavan, Nirmal; Reddy, S. N.; KurunjiKumaran, N. // Journal of International Dental & Medical Research;2012, Vol. 5 Issue 3, p136 

    In orthodontics attaining absolute anchorage is one of the greater tasks for successful outcome of the treatment. The purpose of this study was to investigate the inhibitory effect of locally administered bisphosphonate - pamidronate on orthodontic tooth movement (OTM) in Newzealand albino male...

  • Impact of Bisphosphonate on Orthodontic tooth movement and osteoclastic count: An Animal Study. Venkataramana, V.; Chidambaram, S.; Reddy, B. Vishnuvardhan; Goud, E. V. Soma Shekara; Arafath, Mohammed; Krishnan, Santhana // Journal of International Oral Health;2014, Vol. 6 Issue 2, p1 

    Background: The aim of the current study is to examine the effect of systemically administered BP-Pamidronate, on Orthodontic Tooth Movement (OTM) along with osteoclastic quantification in New Zealand white rabbits. Materials & Methods: Twenty rabbits used in the study, were equally divided into...

  • Pregnancy-associated spinal osteoporosis treated with bisphosphonates: long-term follow-up of maternal and infants outcome. Vujasinovic-Stupar, Nada; Pejnovic, Nada; Markovic, Ljiljana; Zlatanovic, Maja // Rheumatology International;Mar2012, Vol. 32 Issue 3, p819 

    Pregnancy-associated spinal osteoporosis (PPSO) is a rare condition characterized by severe back pain occurring near the end of the first pregnancy or shortly afterward. The aim of this report is to present a 12-year follow-up of a patient with PPSO. Also, the outcomes of patient's two...

  • Pamidronate infusion improved two cases of intractable seronegative rheumatoid arthritise. Salesi1, Mansour; Mottaghi2, Peyman // Journal of Research in Medical Sciences;May2011, Vol. 16 Issue 5, p703 

    Pamidronate is a bisphosphonate derivative that can inhibit bone resorption by actions on osteoclasts and increase bone density in spite of treatment with steroids. This drug has the anti-inflammatory effect by increase apoptosis of monocytes. 5-10 percent of rheumatoid arthritis patients is...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics